S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Haleon (HLN) Competitors

GBX 325.80
+4.60 (+1.43%)
(As of 04/19/2024 ET)

HLN vs. SN, GSK, HIK, HCM, INDV, BMK, APH, BXP, AGY, and ANCR

Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Smith & Nephew (SN), GSK (GSK), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Benchmark (BMK), Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), Allergy Therapeutics (AGY), and Animalcare Group (ANCR). These companies are all part of the "medical" sector.

Haleon vs.

Haleon (LON:HLN) and Smith & Nephew (LON:SN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Haleon presently has a consensus target price of GBX 356, suggesting a potential upside of 9.27%. Smith & Nephew has a consensus target price of GBX 1,362.50, suggesting a potential upside of 40.93%. Given Smith & Nephew's stronger consensus rating and higher probable upside, analysts plainly believe Smith & Nephew is more favorable than Haleon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haleon
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Smith & Nephew
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Smith & Nephew received 544 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 61.83% of users gave Smith & Nephew an outperform vote while only 27.78% of users gave Haleon an outperform vote.

CompanyUnderperformOutperform
HaleonOutperform Votes
10
27.78%
Underperform Votes
26
72.22%
Smith & NephewOutperform Votes
554
61.83%
Underperform Votes
342
38.17%

Haleon has a net margin of 9.28% compared to Smith & Nephew's net margin of 4.74%. Haleon's return on equity of 6.70% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Haleon9.28% 6.70% 4.28%
Smith & Nephew 4.74%5.02%4.27%

In the previous week, Haleon and Haleon both had 2 articles in the media. Smith & Nephew's average media sentiment score of 0.53 beat Haleon's score of 0.33 indicating that Smith & Nephew is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haleon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Smith & Nephew
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

31.6% of Haleon shares are owned by institutional investors. Comparatively, 55.6% of Smith & Nephew shares are owned by institutional investors. 22.5% of Haleon shares are owned by insiders. Comparatively, 0.2% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.8%. Smith & Nephew pays an annual dividend of GBX 30 per share and has a dividend yield of 3.1%. Haleon pays out 5,454.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew pays out 12,500.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haleon£11.30B2.63£1.05B£0.112,961.82
Smith & Nephew£5.55B1.52£263M£0.244,028.33

Summary

Smith & Nephew beats Haleon on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLN vs. The Competition

MetricHaleonDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£29.75B£1.37B£4.80B£1.45B
Dividend Yield1.82%3.06%2.94%12.34%
P/E Ratio2,961.821,233.69269.161,826.27
Price / Sales2.6310,395.182,456.86336,679.87
Price / Cash21.959.7147.1032.28
Price / Book1.813.304.552.56
Net Income£1.05B£168.17M£104.05M£184.45M
7 Day Performance0.90%-1.37%-4.50%-0.58%
1 Month Performance1.69%2.99%-6.08%12.79%
1 Year Performance-5.18%20.70%6.70%17.21%

Haleon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SN
Smith & Nephew
2.8425 of 5 stars
GBX 958.60
-0.3%
GBX 1,362.50
+42.1%
-19.9%£8.38B£5.55B3,994.1718,452Analyst Report
High Trading Volume
GSK
GSK
0.766 of 5 stars
GBX 1,610.50
-2.0%
GBX 1,630.63
+1.2%
+6.7%£65.87B£30.33B1,342.0870,212Analyst Report
HIK
Hikma Pharmaceuticals
0.9913 of 5 stars
GBX 1,786
-1.2%
GBX 2,068.75
+15.8%
-1.6%£3.96B£2.88B2,665.679,100
HCM
HUTCHMED
0 of 5 stars
GBX 268
-6.6%
N/A-4.2%£2.29B£838M2,680.001,988Gap Up
INDV
Indivior
1.3745 of 5 stars
GBX 1,538
-2.1%
GBX 2,515
+63.5%
+4.8%£2.09B£1.09B153,800.001,164Positive News
Gap Down
BMK
Benchmark
0 of 5 stars
GBX 42.40
-1.2%
N/A+19.8%£313.57M£155.53M-1,413.33823
APH
Alliance Pharma
2.887 of 5 stars
GBX 36.30
-2.6%
GBX 80.75
+122.5%
-38.2%£196.17M£170.05M-3,630.00285
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 36.50
flat
N/A-12.4%£162.83M£41.65B456.255,700
AGY
Allergy Therapeutics
0 of 5 stars
GBX 2.85
flat
N/A-54.4%£135.95M£59.59M-47.50612News Coverage
ANCR
Animalcare Group
0 of 5 stars
GBX 217
-1.4%
N/A+18.6%£130.44M£74.35M10,850.00220Gap Down
High Trading Volume

Related Companies and Tools

This page (LON:HLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners